prostate-report.org

Obesity and prostate cancer risk

Some prior studies have suggested a relationship between obesity and adverse pathologic features on prostate biopsy and have suggested that obese patients may ber at higher risk for prostate cancer-related death after radical prostatectomy. However, other studies have been unable to demonstrate any relationship between obesity and clinical risks from prostate cancer.

A research group at Tacoma/Valley Radiation Oncology Centers, has now investigated the potential relationship between body mass index (BMI) and prostate cancer pathology.

The authors conclude that, obesity did not predispose toward higher Gleason score, larger cancer volume, or geographic cancer distribution on repeat biopsy However, it is hard to know exactly what to make of these data simply because this was hardly a “representative” group of patients.